KALV logo

KALV

KalVista Pharmaceuticals Inc.

$13.46
-$0.05(-0.37%)
37
Overall
--
Value
36
Tech
39
Quality
Market Cap
$657.39M
Volume
436.47K
52W Range
$7.30 - $16.32
Target Price
$31.67
Order:

Income Statement

MetricTrendChart
2020
Apr
2021
Apr
2022
Apr
2023
Apr
2024
Apr
2025
Apr
REVENUE
Total Revenue
$12.7M----------
Total Revenue
$12.7M----------
GROSS PROFIT
Gross Profit
$12.7M----------
OPERATING EXPENSES
Operating Expenses
$53.2M$57.9M$96.6M$110.9M$140.4M$188.0M
Research & Development
$40.2M$41.3M$70.2M$80.3M$86.2M$71.7M
Research Expense
$40.2M$41.3M$70.2M$80.3M$86.2M$71.7M
Selling, General & Administrative
$13.0M$16.6M$26.4M$30.6M$54.3M$116.3M
General & Administrative Expenses
$13.0M$16.6M$26.4M$30.6M$54.3M$116.3M
Depreciation & Amortization
$512.0K$500.0K$600.0K$700.0K$800.0K--
Depreciation & Amortization
$512.0K$500.0K$600.0K$700.0K----
Other Operating Expenses
$857.0K$1.1M$1.9M$2.0M----
OPERATING INCOME
Operating income
$-40.5M$-57.9M$-96.6M$-110.9M$-140.4M$-188.0M
EBITDA
$-28.5M$-45.1M$-79.2M$-91.2M$-125.8M$-173.3M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
----------$5.8M
Intinc
$1.8M$903.0K$1.1M$2.2M$3.9M$6.4M
Net Non-Operating Interest Income/Expense
$1.8M$903.0K$1.1M$2.2M$3.9M$650.0K
Gain on Sale of Securities
------$-100.0K----
Other Income/Expense
$-9.8M$-9.9M$13.2M$-15.6M$-9.8M$-4.8M
Other Special Charges
$9.8M$9.9M$14.7M$15.6M$9.8M$4.8M
PRE-TAX INCOME
EBIT
$-29.2M$-46.2M$-82.3M$-92.9M$-126.6M$-174.3M
Pre-Tax Income
$-29.2M$-46.2M$-82.3M$-92.9M$-126.6M$-180.1M
INCOME TAX
Tax Provision
$-124.0K--------$3.4M
NET INCOME
Net Income
$-29.1M$-46.2M$-82.3M$-92.9M$-126.6M$-183.4M
Net Income (Continuing Operations)
$-29.1M$-46.2M$-82.3M$-92.9M$-126.6M$-183.4M
Net Income (Discontinued Operations)
$-29.1M$-46.2M$-82.3M$-92.9M$-126.6M$-183.4M
Net Income (Common Stockholders)
$-29.1M$-46.2M$-82.3M$-92.9M$-126.6M$-183.4M
Normalized Income
--$-36.5M------$-178.3M
TOTALS
Total Expenses
$53.2M$57.9M$96.6M$110.9M$140.4M$188.0M
SHARE & EPS DATA
Average Shares Outstanding
$17.7M$19.1M$24.5M$27.9M$36.8M$49.7M
Average Shares Outstanding (Diluted)
$17.7M$19.1M$24.5M$27.9M$36.8M$49.7M
Shares Outstanding
$17.8M$24.4M$24.6M$34.2M$42.7M$50.0M
Basic EPS
$-1.64$-2.42$-3.36$-3.33$-3.44$-3.69
Basic EPS (Continuing Operations)
$-1.64$-2.42$-3.36$-3.33$-3.44$-3.69
Diluted EPS
$-1.64$-2.42$-3.36$-3.33$-3.44$-3.69
Diluted EPS (Continuing Operations)
----$-3.36$-3.33$-3.44$-3.69
OTHER METRICS
Other Gand A
$13.0M$16.6M$26.4M$30.6M$54.3M$116.3M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2KALV$13.46-0.4%436.47K
3
4
5
6

Get KalVista Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.